About Lawley Pharmaceuticals
Lawley Pharmaceuticals is a privately owned pharmaceutical company whose focus is on the transdermal administration of the naturally occurring hormones testosterone, progesterone and oestradiol.
Founded in 1995 by pharmacist Michael Buckley Lawley Pharmaceuticals has grown to become a world leader in research and development of transdermal hormone preparations.
As the principal of Lawley Pharmaceuticals Mr. Buckley has presided over the development, research, clinical trial program, regulatory process, development and marketing of the company.
The Lawley Pharmaceuticals portfolio of products includes:
AndroFeme® 1% cream - Testosterone for women
AndroForte® 2% and AndroForte® 5% - creams - Testosterone for men
ProFeme® 3.2% and 10% creams - Progesterone for women
Natragen® 0.2% cream - Estradiol for women
Completed clinical studies include:
- The effectiveness of transdermal progesterone cream on menopausal symptoms, lipids and bone markers.
- The effects of sequential transdermal progesterone cream on endometrium bleeding pattern and salivary levels in post-menopausal women.
- Evaluation of serum testosterone levels after topical applications of AndroFeme® cream in post menopausal women with symptoms of testosterone deficiency.
- Systemic absorption after transdermal application of labelled Progesterone in Rats.
- Plasma and saliva concentrations of progesterone in pre- and postmenopausal women after topical application of progesterone cream.
- The effect of testosterone replacement therapy on sexuality, mood and cognition of post menopausal women.
- Long-Term pharmacokinetics and clinical efficacy of AndroForte® 5% cream for androgen replacement in hypogonadal men.
- Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.
- The pharmacokinetics of AndroFeme® 1% testosterone cream following two week, once daily application in testosterone deficient women.
Mr. Buckley is a director of Lawley Pharmaceuticals Ltd, Octagon Enterprises Pty Ltd and Pro-Gest Pty Ltd.
Lawley Pharmaceuticals has established strong links with centres of medical research excellence including:
- The Barbara Gross Medical Research Institute, Royal Hospital for Women, Sydney
- The Jean Hailes Medical Research Foundation, Clayton, Melbourne
- The Menopause Unit, King Edward Memorial Hospital, Perth
- Royal Perth Hospital, Dept of Endocrinology, Perth
- Prince Henry Institute of Medical Research, Clayton, Melbourne
- ANZAC Medical Research Institute, Concord Hospital, Sydney
- St George Hospital, Kogarah, Sydney
- Prince Henry’s Institute of Medical Research, Melbourne
- McCusker Foundation for Alzheimer’s Disease Research, Nedlands, Perth
- Neuroscience Centre, Siloam Gleneagles Hospital Lippo Karawaci, Indonesia
He is a member of the Australasian Menopause Society, The Pharmaceutical Society of Australia (WA Branch), the Pharmacy Guild of Australia and the Australian College of Environmental and Nutritional Medicine.